Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
According to the paper by Gray et al, the single biggest cost of
implementing intensive control of blood glucose concentrations in type
2 diabetes relates to the use of home blood glucose
monitoring.1 This is surprising.
Firstly, currently evidence and agreement are lacking on the role of home blood glucose monitoring in type 2 diabetes.
Secondly, for newly diagnosed patients, home blood glucose monitoring does not offer any particular advantage compared with urine testing.2
Thirdly, actual usage of blood glucose strips by patients is much less than the reality of the situation.3
Fourthly, suggestions have been made of an inverse relation between the frequency of blood testing in type 2 diabetes and achieved concentrations of glycated haemoglobin.4
We have adopted a new approach in Bournemouth for patients with type 2 diabetes in whom home blood glucose monitoring is indicated (patients
with altered renal threshold for glucose, those at risk of
hypoglycaemia,